480
Participants
Start Date
January 31, 2007
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Alogliptin
Alogliptin 6.25 mg, tablets, orally, once daily for up to 12 weeks
Alogliptin
Alogliptin 12.5 mg, tablets, orally, once daily for up to 12 weeks.
Alogliptin
Alogliptin 25 mg, tablets, orally, once daily for up to 12 weeks.
Alogliptin
Alogliptin 50 mg, tablets, orally, once daily for up to 12 weeks
Voglibose
Voglibose 0.2 mg, tablets, orally, three times daily for up to 12 weeks.
Placebo
Placebo-matching tablets, orally, once or three times daily for up to 12 weeks.
Okayama
Lead Sponsor
Takeda
INDUSTRY